Politics and Covid fail to dent UK fee pool optimism

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
People and Markets
Comment
Southpaw

Politics and Covid fail to dent UK fee pool optimism

David Rothnie
January 14, 2021 05:15 PM
AstraZeneca_PA_575x375_14January2021
A medical syringe and vials are seen in front of AstraZeneca logo in this creative photo illustration. The European Medicines Agency (EMA) received an application for conditional marketing authorization of the COVID-19 vaccine developed by AstraZeneca and Oxford University, as media reported on 12 January 2021. (Photo by STR/NurPhoto) | STR/NurPhoto/PA Images

Bankers are betting on a strong year for the UK — Europe’s biggest fee pool — but the overlapping concerns of Brexit, Covid-19 and regulation make for an uncertain outlook, writes David Rothnie.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

EquityEMEACorporate BondsSouthpawNews contentLoans and High YieldLevFin High Yield BondsLeveraged LoansSynd Loans People and MarketsCommentLevFin Leveraged LoansLevFin People and MarketsEuropeCorp People and MarketsInvestment Grade LoansEquity People and MarketsSyndicated LoansCitiPeople and MarketsBank StrategyTop StoriesHigh yieldLevFinHigh grade and crossover bonds
DR
David Rothnie
Gift this article